pH Dynamics in Cancer Cell Biology

Dynamic regulation of pH gradients is fundamental to cancer cell metabolism, proliferation and invasion. Cancer cells establish a reversed pH gradient—elevated intracellular pH and an acidic extracellular microenvironment—through coordinated activity of proton pumps, exchangers and transporters. This proton reversal supports aerobic glycolysis, drives acid extrusion and promotes immune evasion. Key regulators encompass Na+/H+ exchangers, bicarbonate transporters, vacuolar ATPases and monocarboxylate transporters, whose expression and localisation vary across tumour types and microenvironments. Sustained intracellular alkalinity facilitates DNA synthesis, cytoskeletal remodelling and resistance to apoptosis, whereas extracellular acidosis enhances matrix degradation, angiogenesis and metastatic potential. Advances in biosensors have enabled real-time mapping of pH dynamics at subcellular resolution, revealing organelle-specific acidification patterns that influence metabolic flux and signal transduction. Therapeutic strategies aiming to normalise pH dynamics include small-molecule inhibitors, antibodies targeting specific transporters and chemogenetic tools that allow spatiotemporal modulation of proton flux. Understanding the interplay between pH regulation and oncogenic pathways has elaborated novel vulnerabilities, offering opportunities for selective disruption of tumour homeostasis and the development of pH-targeted diagnostics and therapeutics.

Research from Nature Portfolio

Recent studies have uncovered a hypoxia-driven mechanism wherein the Na+/H+ exchanger NHE6 is redistributed from endosomal compartments to the plasma membrane in response to low oxygen tension. This relocalisation triggers persistent endosomal hyperacidification, reinforcing an intracellular pH gradient that sequesters weakly basic chemotherapeutic agents within vesicles and contributes to multidrug resistance. Inhibition of NHE6 trafficking restored drug distribution and sensitised tumour cells to treatment in preclinical models.

Investigations in pancreatic ductal adenocarcinoma have identified the bicarbonate transporter SLC4A4 as a critical modulator of tumour microenvironment acidity. Genetic or pharmacological blockade of SLC4A4 in vitro and in vivo elevated extracellular bicarbonate levels, attenuated glycolytic lactate production and reduced the immunosuppressive milieu. Combined targeting of SLC4A4 and immune checkpoint blockade overcame resistance to immunotherapy and suppressed metastatic progression, highlighting a pH-centric therapeutic avenue.

pH Dynamics in Cancer Cell Biology publication trend

The graph below shows the total number of articles in ph dynamics in cancer cell biology across all publications each year (not limited to Nature Index journals).

Technical terms

Intracellular pH (pHi): The measure of acidity within the cytosol, influencing enzyme activity and signal transduction.

Extracellular pH (pHe): The acidity of the tumour microenvironment, affecting drug uptake and matrix remodelling.

Proton reversal: The characteristic inversion of normal pH gradients in cancer, with raised pHi and lowered pHe.

NHE6 (Na+/H+ exchanger isoform 6): A vesicular transporter that exchanges cytosolic protons for extracellular sodium ions, regulating endosomal pH.

SLC4A4: A sodium-bicarbonate cotransporter that imports bicarbonate to neutralise extracellular acidity.

AE2 (SLC4A2): An anion exchanger that loads cells with bicarbonate and chloride, contributing to intracellular acid–base balance.

NBCn1 (SLC4A7): A sodium-bicarbonate cotransporter that extrudes protons indirectly by importing bicarbonate to maintain cytosolic alkalinity.

Chemogenetic pH-Control: A genetically encoded enzymatic system activated by an exogenous substrate to induce localised acidification in living cells.

References

1. Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance. Nature Communications (2017).
2. Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nature Cancer (2022).
3. Development of a Chemogenetic Approach to Manipulate Intracellular pH. Journal of the American Chemical Society (2023).
4. Acid-adapted cancer cells alkalinize their cytoplasm by degrading the acid-loading membrane transporter anion exchanger 2, SLC4A2. Cell Reports (2023).
5. Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer. British Journal of Cancer (2024).